Please login to the form below

Not currently logged in
Email:
Password:

BTG

This page shows the latest BTG news and features for those working in and with pharma, biotech and healthcare.

Generic threat looms to J&J’s blockbuster Zytiga in US

Generic threat looms to J&J’s blockbuster Zytiga in US

BTG impacted. Meanwhile, declining Zytiga sales would also impact BTG, which gets a royalty stream from the product that accounted for 28% of its first half revenues, according to analyst Andy ... News of the denied injunction came the day after Boston

Latest news

  • Boston Scientific makes $4.2bn play for UK’s BTG Boston Scientific makes $4.2bn play for UK’s BTG

    licensing revenues that accounted for almost a third of BTG’s $496m turnover in the first half of this year. ... Shareholders representing around 33% of BTG’s issued stock have already agreed to back the takeover.

  • Belgium's Ablynx enters the US market Belgium's Ablynx enters the US market

    Schneider moves to Ablynx from BTG International, where he served as general manager of its specialty pharmaceutical business unit.

  • BTG acquires Roxwood Medical BTG acquires Roxwood Medical

    Will pay up to $80m for the catheter specialist. Global healthcare company BTG has acquired Roxwood Medical, a provider of cardiovascular speciality catheters used to treat patients with severe coronary and ... With the expanded commercial and clinical

  • VCCP Health takes lead at PM Society Awards VCCP Health takes lead at PM Society Awards

    DigiFab for BTG by Cherry. Craft Award for Journal Advertisement Campaign.

  • BTG rises on FDA approval of varicose vein therapy BTG rises on FDA approval of varicose vein therapy

    Treatment is a minimally invasive, non-surgical procedure that requires neither tumescent anaesthesia nor sedation," said BTG in a statement. ... Given that BTG's total revenues were £234 in fiscal 2012/13, Varithena's approval looks set to be a

More from news
Approximately 3 fully matching, plus 19 partially matching documents found.

Latest Intelligence

  • Deal Watch May 2016 Deal Watch May 2016

    140. Galil Medical/ BTG. Corporate acquisition. Cryoablation products for treatment and palliative care of kidney and other cancers; $84.5m upfront and up to $25.5m in milestones.

  • Deal Watch table for January 2015 Deal Watch table for January 2015

    Collaboration agreement. 480. PneumRx/BTG. Includes RePneu a coil to open airways in emphysema patients.

  • Deal Watch table for December 2014 Deal Watch table for December 2014

    Company acquisition. 489. PneumRx / BTG. Portfolio of medical devices for interventional pulmonology inc RePneu Coil.

  • Interview: Michel Pettigrew, Ferring Interview: Michel Pettigrew, Ferring

    A much larger example of the policy came in the wake of Ferring's 2005 acquisition of Bio-Technology General (BTG). ... It purchased the Israeli biopharmaceutical services company in order to fully integrate the growth hormone Zomacton, which had been

  • Deal Watch table for May 2013 Deal Watch table for May 2013

    Adasuve approved for acute agitation. 235. EKOS/ BTG. Company acquisition. Device for treating blood clots. ... 220. Therasphere/ BTG. Asset purchase. Treatment for liver cancer. 200. Aradigm/ Grifols .

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Ferring Pharmaceuticals promotes Aaron Graff Ferring Pharmaceuticals promotes Aaron Graff

    After leading the acquisition and integration of Israeli biopharmaceutical company BTG in 2005, he relocated his team to the newly established Ferring International Center in Saint-Prex.

  • ProStrakan lines up new chairman for 2014 ProStrakan lines up new chairman for 2014

    Dr Brown also co-chairs the Scottish Government's Life Science Industry Advisory Board and was formerly chairman of BTG, Axis-Shield and, prior to that, chief executive of Acambis.

  • John Brown to chair Cell Therapy Catapult John Brown to chair Cell Therapy Catapult

    Dr Brown has great experience in the life sciences industry, holding such positions as chairman of medical diagnostics company Axis-Shield and chair of specialist healthcare company, BTG.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Random42 Scientific Communication

    Boston Biomedical. Boston Scientific . Bristol-Myers Squibb. BTG. Celgene. Ceva. Chiesi. Cidara Therapeutics. ... VP, US Marketing, BTG. "Thanks for excellent work!". - Business Unit Manager, Mundipharma.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics